A Role for Histone Deacetylase HDAC1 in Modulating the Transcriptional Activity of MyoD: Inhibition of the Myogenic Program

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2001 Apr 4

PMID 11285237

Citations 118

Authors

A Mal

M Sturniolo

R L Schiltz

M K Ghosh

M L Harter

Affiliations

Soon will be listed here.

Abstract

The molecular mechanism(s) that are responsible for suppressing MyoD's transcriptional activities in undifferentiated skeletal muscle cells have not yet been determined. We now show that MyoD associates with a histone deacetylase-1 (HDAC1) in these cells and that this interaction is responsible for silencing MyoD-dependent transcription of endogenous p21 as well as muscle-specific genes. Specifically, we present evidence that HDAC1 can bind directly to MyoD and use an acetylated MyoD as a substrate in vitro, whereas a mutant version of HDAC1 (H141A) can not. Further more, this mutant also fails to repress MyoD-mediated transcription in vivo, and unlike wild-type HDAC1 it can not inhibit myogenic conversion, as judged by confocal microscopy. Finally, we show that an endogenous MyoD can be acetylated upon its conversion to a hypophosphorylated state and only when the cells have been induced to differentiate. These results provide for a model which postulates that MyoD may be co-dependent on HDAC1 and P/CAF for temporally controlling its transcriptional activity before and after the differentiation of muscle cells.

Citing Articles

E-box independent chromatin recruitment turns MYOD into a transcriptional repressor.

Nicoletti C, Massenet J, Pintado-Urbanc A, Connor L, Nicolau M, Sundar S bioRxiv. 2024; .

PMID: 39677796 PMC: 11643108. DOI: 10.1101/2024.12.05.627024.

Emerging role of HDAC11 in skeletal muscle biology.

Chen J, Li Q Front Cell Dev Biol. 2024; 12:1368171.

PMID: 38859964 PMC: 11163118. DOI: 10.3389/fcell.2024.1368171.

HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients.

Mozzetta C, Sartorelli V, Steinkuhler C, Puri P Trends Mol Med. 2024; 30(3):278-294.

PMID: 38408879 PMC: 11095976. DOI: 10.1016/j.molmed.2024.01.007.

The Current Landscape of Pharmacotherapies for Sarcopenia.

Bahat G, Ozkok S Drugs Aging. 2024; 41(2):83-112.

PMID: 38315328 DOI: 10.1007/s40266-023-01093-7.

Integrated Transcriptome Analysis of miRNAs and mRNAs in the Skeletal Muscle of Wuranke Sheep.

Yun Y, Wu R, He X, Qin X, Chen L, Sha L Genes (Basel). 2023; 14(11).

PMID: 38002977 PMC: 10671749. DOI: 10.3390/genes14112034.

References

Parker S, Eichele G, Zhang P, Rawls A, Sands A, Bradley A . p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science. 1995; 267(5200):1024-7. DOI: 10.1126/science.7863329. View

Spicer D, Rhee J, Cheung W, Lassar A . Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist. Science. 1996; 272(5267):1476-80. DOI: 10.1126/science.272.5267.1476. View

Eckner R, Yao T, Oldread E, Livingston D . Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 1996; 10(19):2478-90. DOI: 10.1101/gad.10.19.2478. View

Lassar A, Buskin J, Lockshon D, Davis R, Apone S, Hauschka S . MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell. 1989; 58(5):823-31. DOI: 10.1016/0092-8674(89)90935-5. View

Naya F, Olson E . MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol. 1999; 11(6):683-8. DOI: 10.1016/s0955-0674(99)00036-8. View

Skapek S, Rhee J, Kim P, Novitch B, Lassar A . Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol Cell Biol. 1996; 16(12):7043-53. PMC: 231707. DOI: 10.1128/MCB.16.12.7043. View

Weintraub H . The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell. 1993; 75(7):1241-4. DOI: 10.1016/0092-8674(93)90610-3. View

Polesskaya A, Duquet A, Naguibneva I, Weise C, Vervisch A, Bengal E . CREB-binding protein/p300 activates MyoD by acetylation. J Biol Chem. 2000; 275(44):34359-64. DOI: 10.1074/jbc.M003815200. View

Korzus E, Torchia J, Rose D, Xu L, Kurokawa R, McInerney E . Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science. 1998; 279(5351):703-7. DOI: 10.1126/science.279.5351.703. View

10.

Sartorelli V, Huang J, Hamamori Y, Kedes L . Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol. 1997; 17(2):1010-26. PMC: 231826. DOI: 10.1128/MCB.17.2.1010. View

11.

Guo K, Walsh K . Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J Biol Chem. 1997; 272(2):791-7. DOI: 10.1074/jbc.272.2.791. View

12.

Maione R, Amati P . Interdependence between muscle differentiation and cell-cycle control. Biochim Biophys Acta. 1997; 1332(1):M19-30. DOI: 10.1016/s0304-419x(96)00036-4. View

13.

Luo R, Postigo A, Dean D . Rb interacts with histone deacetylase to repress transcription. Cell. 1998; 92(4):463-73. DOI: 10.1016/s0092-8674(00)80940-x. View

14.

Lassar A, Skapek S, Novitch B . Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr Opin Cell Biol. 1994; 6(6):788-94. DOI: 10.1016/0955-0674(94)90046-9. View

15.

Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain J, Troalen F . Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature. 1998; 391(6667):601-5. DOI: 10.1038/35410. View

16.

Bartl S, Taplick J, Lagger G, Khier H, Kuchler K, Seiser C . Identification of mouse histone deacetylase 1 as a growth factor-inducible gene. Mol Cell Biol. 1997; 17(9):5033-43. PMC: 232354. DOI: 10.1128/MCB.17.9.5033. View

17.

Siavoshian S, Segain J, Kornprobst M, Bonnet C, Cherbut C, Galmiche J . Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut. 2000; 46(4):507-14. PMC: 1727889. DOI: 10.1136/gut.46.4.507. View

18.

Yuan W, Condorelli G, Caruso M, Felsani A, Giordano A . Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem. 1996; 271(15):9009-13. DOI: 10.1074/jbc.271.15.9009. View

19.

Martinez-Balbas M, Bauer U, Nielsen S, Brehm A, Kouzarides T . Regulation of E2F1 activity by acetylation. EMBO J. 2000; 19(4):662-71. PMC: 305604. DOI: 10.1093/emboj/19.4.662. View

20.

Boyes J, Byfield P, Nakatani Y, Ogryzko V . Regulation of activity of the transcription factor GATA-1 by acetylation. Nature. 1998; 396(6711):594-8. DOI: 10.1038/25166. View